Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with
Employees: 1-10
Founded date: 2018
Investment Type: Venture Capital
Investment Stage: Series B; Series C
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 10.07.2023 | SpyGlass P... | spyglasspharma.com | $90M | United Sta... |
| 25.07.2022 | Cleerly | cleerlyhealth.com | $372M | United Sta... |
| 09.06.2022 | Moxe | moxehealth.com | $60.5M | United Sta... |
Mentions in press and media 12
| Date | Title | Description |
| 26.03.2025 | Evident Vascular Secures Series B Funding to Revolutionize Intravascular Imaging | In the bustling world of medical technology, innovation is the lifeblood. Evident Vascular, a San Jose-based company, has just injected a fresh dose of capital into its veins. On March 25, 2025, the company announced the successful closing ... |
| 25.03.2025 | Evident Vascular Raises Series B Financing to Advance AI-Powered Intravascular Ultrasound Platform Technology | Funding to accelerate development of next-generation intravascular ultrasound platform and support FDA clearance for U.S. market launch SAN JOSE, Calif.–(BUSINESS WIRE)–March 25, 2025– Evident Vascular, Inc., a medical technology company de... |
| 18.04.2024 | Elucent Medical Revolutionizes Surgical Navigation with $42.5M Funding | Elucent Medical, a cutting-edge medical technology company based in Eden Prairie, MN, has secured $42.5M in Series C funding to advance its innovative surgical navigation technologies. Led by Vensana Capital and RC Capital, with participati... |
| 12.04.2024 | Elucent Medical Secures $42.5M to Advance iSI-Powered Surgical Navigation | What You Should Know: – Elucent Medical, a leader in surgical navigation with its In-Site Spatial Intelligence (iSI) technology raises $42.5M in Series C funding, led by Vensana Capital and RC Capital with participation from existing invest... |
| 24.05.2023 | Artelon Secures $20M to Advance Surgical Treatment of Joint Instability | What You Should Know: Artelon Inc., a privately held medical device company raises $20M in Series B funding, led by Vensana Capital with expected additional participation from existing investors. Artelon’s Dynamic Matrix technology is a pro... |
| 05.01.2023 | France's Volta Medical raises €36 million series B to help surgeons treat cardiac arrhythmias and fund more clinical testing | Volta Medical is announcing a €36 million series B fundraise to lift its total investment to above €70 million. Leading the round on this occasion is the US investor Vensana Capital, with participation from Lightstone Ventures and the healt... |
| 15.09.2022 | SpyGlass Pharma to Unveil Innovative Drug Delivery Platform for Chronic Eye Conditions at Eyecelerator Prior to the American Academy of Ophthalmology Meeting | SpyGlass Pharma, Inc. ALISO VIEJO, Calif. (PRWEB) September 15, 2022 SpyGlass Pharma, a privately-held ophthalmic therapeutics company, today announced it will be unveiling a breakthrough drug delivery platform to treat chronic eye conditio... |
| 28.09.2021 | Vensana Capital redoubles medtech investment efforts with $325M 2nd fund | Vensana Capital has set a high bar for its second medtech-focused venture fund. Its first, established in 2019, brought in $225 million, which it proceeded to dole out to a total of 10 startups developing devices, diagnostics, artificial in... |
| 28.09.2021 | Vensana Capital redoubles medtech investment efforts with $325M 2nd fund | Vensana Capital has set a high bar for its second medtech-focused venture fund. Its first, established in 2019, brought in $225 million, which it proceeded to dole out to a total of 10 startups developing devices, diagnostics, artificial in... |
| 21.06.2021 | Cleerly Launches with $43M for Digital Care Pathway Solution for Heart Attack Prevention | What You Should Know: – Cleerly, a New York City-based company launched today with $43M in Series B funding and unveiled its first-of-its-kind digital care pathway solution for heart attack prevention. The Series B funding, which was led by... |
Show more